Evidence map›Paper›PMID 32220656›Full record

ArticleThe lancet. Gastroenterology & hepatology2020

Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.

Fabiana Zingone, Edoardo Vincenzo Savarino

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in The lancet. Gastroenterology & hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
1.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2020
    Guideline
  2. Guideline
  3. Guideline
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. COVID-19 illness and autoimmune diseases: recent insights.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. No need of transforming gastroenterology units to covid units at the time of SARS-COV2 infection - a single-center analysis from northern italy.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2020
    Article
  15. Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.Journal of the European Academy of Dermatology and Venereology : JEADV · 2020
    Review
  16. Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2020
    Article
  17. Article
  18. COVID-19 and its effects on the digestive system and endoscopy practice.JGH open : an open access journal of gastroenterology and hepatology · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Fabiana ZingoneDivision of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, 35121 Padua, Italy. Electronic address: fabiana.zingone@unipd.it.
Edoardo Vincenzo SavarinoDivision of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, 35121 Padua, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusBiological ProductsInflammatory Bowel DiseasesCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2Biological Products

Identifiers

PMID32220656
PMCPMC7270848
OpenAlexW3012605971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.